| Common Name: | SIKAFLEX-291 |
| Manufacturer: | SIKA |
| SDS Revision Date: | 3/30/2021 |
| SDS Format: | No Format Specified |
| Item Number(s): | 34JG99 |
| Manufacturer Model Number(s): |
SDS Table of Contents
Click the desired link below to jump directly to that section in the SDS.
SIKA(R*)
SAFETY DATA SHEET
SIKAFLEX(R*)-291
REVISION DATE: 03/30/2021
PRINT DATE: 03/30/2021
| SECTION 1. IDENTIFICATION |  |
PRODUCT NAME: SIKAFLEX(R*)-291
COMPANY NAME:
SIKA CORPORATION
201 POLITO AVENUE
LYNDHURST, NJ 07071
USA
WWW.SIKAUSA.COM
TELEPHONE: (201) 933-8800
TELEFAX: (201) 804-1076
E-MAIL ADDRESS: EHS@SIKA-CORP.COM
EMERGENCY TELEPHONE:
CHEMTREC: 800-424-9300
INTERNATIONAL: +1-703-527-3887
RECOMMENDED USE OF THE CHEMICAL AND RESTRICTIONS ON USE:
FOR FURTHER INFORMATION, REFER TO PRODUCT DATA SHEET.
| SECTION 2. HAZARDS IDENTIFICATION | |
GHS CLASSIFICATION IN ACCORDANCE WITH THE OSHA HAZARD COMMUNICATION
STANDARD (29 CFR 1910.1200)
RESPIRATORY SENSITIZATION: CATEGORY 1
SKIN SENSITIZATION: CATEGORY 1
CARCINOGENICITY (INHALATION): CATEGORY 1A
SPECIFIC TARGET ORGAN TOXICITY - REPEATED EXPOSURE (INHALA-TION):
CATEGORY 2
GHS LABEL ELEMENTS:
HAZARD PICTOGRAMS: HEALTH HAZARD
SIGNAL WORD: DANGER
HAZARD STATEMENTS:
H317: MAY CAUSE AN ALLERGIC SKIN REACTION.
H334:
MAY CAUSE ALLERGY OR ASTHMA SYMPTOMS OR BREATHING DIFFI-CULTIES IF INHALED.
H350: MAY CAUSE CANCER BY INHALATION.
H373:
MAY CAUSE DAMAGE TO ORGANS THROUGH PROLONGED OR REPEATED EXPOSURE IF
INHALED.
PRECAUTIONARY STATEMENTS:
PREVENTION:
P201: OBTAIN SPECIAL INSTRUCTIONS BEFORE USE.
P202:
DO NOT HANDLE UNTIL ALL SAFETY PRECAUTIONS HAVE BEEN READ AND UNDERSTOOD.
P260: DO NOT BREATHE DUST/ FUME/ GAS/ MIST/ VAPORS/ SPRAY.
P272: CONTAMINATED WORK CLOTHING MUST NOT BE ALLOWED OUT OF THE WORKPLACE.
P280:
WEAR PROTECTIVE GLOVES/ PROTECTIVE CLOTHING/ EYE PROTECTION/ FACE
PROTECTION.
P284: WEAR RESPIRATORY PROTECTION.
RESPONSE:
P302 + P352:
IF ON SKIN: WASH WITH PLENTY OF SOAP AND WATER.
P304 + P340:
IF INHALED: REMOVE PERSON TO FRESH AIR AND KEEP COMFORTABLE FOR BREATHING.
P308 + P313:
IF EXPOSED OR CONCERNED: GET MEDICAL ADVICE/ ATTENTION.
P333 + P313:
IF SKIN IRRITATION OR RASH OCCURS: GET MEDICAL ADVICE/ ATTENTION.
P362 + P364: TAKE OFF CONTAMINATED CLOTHING AND WASH IT BEFORE REUSE.
STORAGE:
P405: STORE LOCKED UP.
DISPOSAL:
P501: DISPOSE OF CONTENTS/ CONTAINER TO AN APPROVED WASTE DISPOSAL PLANT.
ADDITIONAL LABELING:
THERE ARE NO INGREDIENTS WITH UNKNOWN ACUTE TOXICITY USED IN A MIXTURE AT
A CONCENTRATION >= 1%.
OTHER HAZARDS:
INTENTIONAL MISUSE BY DELIBERATE CONCENTRATION AND INHALATION OF VAPOR MAY
BE HARMFUL OR FATAL.
| SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS | |
MIXTURES:
COMPONENTS:
CHEMICAL NAME CAS-NO. CLASSIFICATION CONCENTRATION
(% W/W)
XYLENE 1330-20-7 FLAM. LIQ. 3; H226 >= 1 - <5
ACUTE TOX. 4; H332
ACUTE TOX. 4; H312
SKIN IRRIT. 2; H315
EYE IRRIT. 2A; H319
STOT SE 3; H335
STOT RE 2; H373
ASP. TOX. 1; H304
4,4'-METHYLENEDIPHENYL 101-68-8 ACUTE TOX. 4; H332 >= 0.1 - <1
DIISOCYANATE SKIN IRRIT. 2; H315
EYE IRRIT. 2B; H320
RESP. SENS. 1; H334
SKIN SENS. 1; H317
STOT SE 3; H335
STOT RE 2; H373
ETHYLBENZENE 100-41-4 FLAM. LIQ. 2; H225 >= 0.1 - <1
ACUTE TOX. 4; H332
STOT RE 2; H373
ASP. TOX. 1; H304
EYE IRRIT. 2A; H319
QUARTZ (SiO2) 14808-60-7 CARC. 1A; H350I >= 0.1 - <1
STOT RE 1; H372
STOT SE 3; H335
ACTUAL CONCENTRATION IS WITHHELD AS A TRADE SECRET
| SECTION 4. FIRST AID MEASURES | |
GENERAL ADVICE:
MOVE OUT OF DANGEROUS AREA.
CONSULT A PHYSICIAN.
SHOW THIS MATERIAL SAFETY DATA SHEET TO THE DOCTOR IN ATTENDANCE.
IF INHALED:
MOVE TO FRESH AIR.
CONSULT A PHYSICIAN AFTER SIGNIFICANT EXPOSURE.
IN CASE OF SKIN CONTACT:
TAKE OFF CONTAMINATED CLOTHING AND SHOES IMMEDIATELY.
WASH OFF WITH SOAP AND PLENTY OF WATER.
IF SYMPTOMS PERSIST, CALL A PHYSICIAN.
IN CASE OF EYE CONTACT:
REMOVE CONTACT LENSES.
KEEP EYE WIDE OPEN WHILE RINSING.
IF EYE IRRITATION PERSISTS, CONSULT A SPECIALIST.
IF SWALLOWED:
CLEAN MOUTH WITH WATER AND DRINK AFTERWARDS PLENTY OF WATER.
DO NOT INDUCE VOMITING WITHOUT MEDICAL ADVICE.
DO NOT GIVE MILK OR ALCOHOLIC BEVERAGES.
NEVER GIVE ANYTHING BY MOUTH TO AN UNCONSCIOUS PERSON.
OBTAIN MEDICAL ATTENTION.
MOST IMPORTANT SYMPTOMS AND EFFECTS, BOTH ACUTE AND DELAYED:
ASTHMATIC APPEARANCE
ALLERGIC REACTIONS
SENSITIZING EFFECTS
MAY CAUSE AN ALLERGIC SKIN REACTION.
MAY CAUSE ALLERGY OR ASTHMA SYMPTOMS OR BREATHING DIFFICUL-TIES IF INHALED.
MAY CAUSE CANCER BY INHALATION.
MAY CAUSE DAMAGE TO ORGANS THROUGH PROLONGED OR REPEATED EXPOSURE IF
INHALED.
NOTES TO PHYSICIAN: TREAT SYMPTOMATICALLY.
| SECTION 5. FIRE-FIGHTING MEASURES | |
SUITABLE EXTINGUISHING MEDIA:
USE EXTINGUISHING MEASURES THAT ARE APPROPRIATE TO LOCAL CIR-CUMSTANCES
AND THE SURROUNDING ENVIRONMENT.
FURTHER INFORMATION:
COLLECT CONTAMINATED FIRE EXTINGUISHING WATER SEPARATELY. THIS MUST NOT BE
DISCHARGED INTO DRAINS.
FIRE RESIDUES AND CONTAMINATED FIRE EXTINGUISHING WATER MUST BE DISPOSED
OF IN ACCORDANCE WITH LOCAL REGULATIONS.
SPECIAL PROTECTIVE EQUIPMENT FOR FIRE-FIGHTERS:
IN THE EVENT OF FIRE, WEAR SELF-CONTAINED BREATHING APPARATUS.
| SECTION 6. ACCIDENTAL RELEASE MEASURES | |
PERSONAL PRECAUTIONS, PROTECTIVE EQUIPMENT AND EMERGENCY PROCEDURES:
USE PERSONAL PROTECTIVE EQUIPMENT.
DENY ACCESS TO UNPROTECTED PERSONS.
ENVIRONMENTAL PRECAUTIONS:
DO NOT FLUSH INTO SURFACE WATER OR SANITARY SEWER SYSTEM.
LOCAL AUTHORITIES SHOULD BE ADVISED IF SIGNIFICANT SPILLAGES CANNOT BE
CONTAINED.
METHODS AND MATERIALS FOR CONTAINMENT AND CLEANING UP:
SOAK UP WITH INERT ABSORBENT MATERIAL (E.G. SAND, SILICA GEL, ACID BINDER,
UNIVERSAL BINDER, SAWDUST).
KEEP IN SUITABLE, CLOSED CONTAINERS FOR DISPOSAL.
| SECTION 7. HANDLING AND STORAGE | |
ADVICE ON PROTECTION AGAINST FIRE AND EXPLOSION:
NORMAL MEASURES FOR PREVENTIVE FIRE PROTECTION.
ADVICE ON SAFE HANDLING:
AVOID EXCEEDING THE GIVEN OCCUPATIONAL EXPOSURE LIMITS (SEE SECTION 8).
DO NOT GET IN EYES, ON SKIN, OR ON CLOTHING.
FOR PERSONAL PROTECTION SEE SECTION 8.
PERSONS WITH A HISTORY OF SKIN SENSITIZATION PROBLEMS OR ASTHMA, ALLERGIES,
CHRONIC OR RECURRENT RESPIRATORY DISEASE SHOULD NOT BE EMPLOYED IN ANY
PROCESS IN WHICH THIS MIXTURE IS BEING USED.
SMOKING, EATING AND DRINKING SHOULD BE PROHIBITED IN THE AP-PLICATION AREA.
FOLLOW STANDARD HYGIENE MEASURES WHEN HANDLING CHEMICAL PRODUCTS.
CONDITIONS FOR SAFE STORAGE:
STORE IN ORIGINAL CONTAINER.
KEEP CONTAINER TIGHTLY CLOSED IN A DRY AND WELL-VENTILATED PLACE.
OBSERVE LABEL PRECAUTIONS.
STORE IN ACCORDANCE WITH LOCAL REGULATIONS.
| SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION | |
INGREDIENTS WITH WORKPLACE CONTROL PARAMETERS:
COMPONENTS CAS-NO. VALUE TYPE CONTROL PARAMETERS BASIS
(FORM OF / PERMISSIBLE
EXPOSURE) CONCENTRATION
XYLENE 1330-20-7 TWA 100 PPM OSHA Z-1
435 MG/M3
TWA 100 PPM ACGIH
STEL 150 PPM ACGIH
STEL 150 PPM OSHA P0
655 MG/M3
TWA 100 PPM OSHA P0
435 MG/M3
4,4'-METHYLENE- 101-68-8 TWA 0.005 PPM ACGIH
DIPHENYL
DIISOCYANATE C 0.02 PPM OSHA Z-1
0.2 MG/M3
C 0.02 PPM OSHA P0
0.2 MG/M3
ETHYLBENZENE 100-41-4 TWA 100 PPM OSHA Z-1
435 MG/M3
TWA 100 PPM OSHA P0
435 MG/M3
STEL 125 PPM OSHA P0
545 MG/M3
QUARTZ (SiO2) 14808-60-7 TWA 0.025 MG/M3 ACGIH
(RESPIRABLE
PARTICULATE
MATTER)
TWA 0.05 MG/M3 OSHA Z-1
(RESPIRABLE
DUST)
TWA 10 MG/M3 / OSHA Z-3
(RESPIRABLE) %SiO2+2
TWA 250 MPPCF / OSHA Z-3
(RESPIRABLE) %SiO2+5
TWA 0.1 MG/M3 OSHA P0
(RESPIRABLE)
DUST FRACTION)
TWA 0.025 MG/M3 ACGIH
(RESPIRABLE) (SILICA)
PARTICULATE
MATTER)
TWA 0.1 MG/M3 OSHA P0
(RESPIRABLE)
DUST FRACTION)
TWA 0.025 MG/M3 ACGIH
(RESPIRABLE)
PARTICULATE
MATTER)
TWA 0.025 MG/M3 ACGIH
(RESPIRABLE) (SILICA)
PARTICULATE
MATTER)
THE ABOVE CONSTITUENTS ARE THE ONLY CONSTITUENTS OF THE PRODUCT WHICH HAVE
A PEL, TLV OR OTHER REC-OMMENDED EXPOSURE LIMIT. AT THIS TIME, THE OTHER
CONSTITUENTS HAVE NO KNOWN EXPOSURE LIMITS.
ENGINEERING MEASURES:
USE OF ADEQUATE VENTILATION SHOULD BE SUFFICIENT TO CONTROL WORKER EXPOSURE
TO AIRBORNE CONTAMINANTS. IF THE USE OF THIS PRODUCT GENERATES DUST, FUMES,
GAS, VAPOR OR MIST, USE PRO-CESS ENCLOSURES, LOCAL EXHAUST VENTILATION OR
OTHER ENGINEER-ING CONTROLS TO KEEP WORKER EXPOSURE BELOW ANY RECOMMENDED
OR STATUTORY LIMITS.
PERSONAL PROTECTIVE EQUIPMENT:
RESPIRATORY PROTECTION:
USE A PROPERLY FITTED NIOSH APPROVED AIR-PURIFYING OR AIR-FED RESPIRATOR
COMPLYING WITH AN APPROVED STANDARD IF A RISK ASSESSMENT INDICATES THIS IS
NECESSARY.
THE FILTER CLASS FOR THE RESPIRATOR MUST BE SUITABLE FOR THE MAXIMUM
EXPECTED CONTAMINANT CONCENTRATION (GAS/VAPOR/AEROSOL/PARTICULATES) THAT
MAY ARISE WHEN HANDLING THE PRODUCT. IF THIS CONCENTRATION IS EXCEEDED,
SELF-CONTAINED BREATHING APPARATUS MUST BE USED.
HAND PROTECTION:
CHEMICAL-RESISTANT, IMPERVIOUS GLOVES COMPLYING WITH AN APPROVED STANDARD
SHOULD BE WORN AT ALL TIMES WHEN HANDLING CHEMICAL PRODUCTS IF A RISK
ASSESSMENT INDICATES THIS IS NECESSARY.
EYE PROTECTION:
SAFETY EYEWEAR COMPLYING WITH AN APPROVED STANDARD SHOULD BE USED WHEN A
RISK ASSESSMENT INDICATES THIS IS NECESSARY.
SKIN AND BODY PROTECTION:
CHOOSE BODY PROTECTION IN RELATION TO ITS TYPE, TO THE CONCENTRATION AND
AMOUNT OF DANGEROUS SUBSTANCES, AND TO THE SPECIFIC WORKPLACE.
HYGIENE MEASURES:
AVOID CONTACT WITH SKIN, EYES AND CLOTHING.
WASH HANDS BEFORE BREAKS AND IMMEDIATELY AFTER HANDLING THE PRODUCT.
REMOVE CONTAMINATED CLOTHING AND PROTECTIVE EQUIPMENT BEFORE ENTERING
EATING AREAS.
WASH THOROUGHLY AFTER HANDLING.
| SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES | |
APPEARANCE: PASTE
COLOR: VARIOUS
ODOR: AROMATIC
ODOR THRESHOLD: NO DATA AVAILABLE
PH: NOT APPLICABLE
MELTING POINT/RANGE / FREEZING POINT: NO DATA AVAILABLE
BOILING POINT/BOILING RANGE: NO DATA AVAILABLE
FLASH POINT: NOT APPLICABLE
EVAPORATION RATE: NO DATA AVAILABLE
FLAMMABILITY (SOLID, GAS): NO DATA AVAILABLE
UPPER EXPLOSION LIMIT / UPPER FLAMMABILITY LIMIT: NO DATA AVAILABLE
LOWER EXPLOSION LIMIT / LOWER FLAMMABILITY LIMIT: NO DATA AVAILABLE
VAPOR PRESSURE: 0.01 HPA
RELATIVE VAPOR DENSITY: NO DATA AVAILABLE
DENSITY: CA. 1.28 G/CM3 (73 DEG. F / 23 DEG. C)
SOLUBILITY(IES):
WATER SOLUBILITY: INSOLUBLE
SOLUBILITY IN OTHER SOLVENTS: NO DATA AVAILABLE
PARTITION COEFFICIENT N-OCTANOL/WATER: NO DATA AVAILABLE
AUTOIGNITION TEMPERATURE: NO DATA AVAILABLE
DECOMPOSITION TEMPERATURE: NO DATA AVAILABLE
VISCOSITY:
VISCOSITY, DYNAMIC: NO DATA AVAILABLE
VISCOSITY, KINEMATIC: >20.5 MM2/S (104 DEG. F / 40 DEG. C)
EXPLOSIVE PROPERTIES: NO DATA AVAILABLE
OXIDIZING PROPERTIES: NO DATA AVAILABLE
VOLATILE ORGANIC COMPOUNDS (VOC) CONTENT: 25 G/L
| SECTION 10. STABILITY AND REACTIVITY | |
REACTIVITY:
NO DANGEROUS REACTION KNOWN UNDER CONDITIONS OF NORMAL USE.
CHEMICAL STABILITY: THE PRODUCT IS CHEMICALLY STABLE.
POSSIBILITY OF HAZARDOUS REACTIONS:
STABLE UNDER RECOMMENDED STORAGE CONDITIONS.
CONDITIONS TO AVOID: NO DATA AVAILABLE
INCOMPATIBLE MATERIALS: NO DATA AVAILABLE
HAZARDOUS DECOMPOSITION PRODUCTS:
NO DECOMPOSITION IF STORED AND APPLIED AS DIRECTED.
| SECTION 11. TOXICOLOGICAL INFORMATION | |
ACUTE TOXICITY:
NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
COMPONENTS:
XYLENE:
ACUTE ORAL TOXICITY:
LD50 ORAL (RAT): 3,523 MG/KG
ACUTE DERMAL TOXICITY:
LD50 DERMAL (RABBIT): 1,700 MG/KG
4,4'-METHYLENEDIPHENYL DIISOCYANATE:
ACUTE ORAL TOXICITY:
LD50 ORAL (RAT): >4,700 MG/KG
METHOD: OECD TEST GUIDELINE 401
ACUTE INHALATION TOXICITY:
LC50: 1.5 MG/L
EXPOSURE TIME: 4 H
TEST ATMOSPHERE: DUST/MIST
METHOD: EXPERT JUDGMENT
ETHYLBENZENE:
ACUTE ORAL TOXICITY:
LD50 ORAL (RAT): 3,500 MG/KG
ACUTE DERMAL TOXICITY:
LD50 DERMAL (RABBIT): 5,510 MG/KG
SKIN CORROSION/IRRITATION: NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
SERIOUS EYE DAMAGE/EYE IRRITATION:
NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
RESPIRATORY OR SKIN SENSITIZATION:
SKIN SENSITIZATION: MAY CAUSE AN ALLERGIC SKIN REACTION.
RESPIRATORY SENSITIZATION:
MAY CAUSE ALLERGY OR ASTHMA SYMPTOMS OR BREATHING DIFFICULTIES IF INHALED.
GERM CELL MUTAGENICITY:
NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
CARCINOGENICITY: MAY CAUSE CANCER BY INHALATION.
IARC:
GROUP 1: CARCINOGENIC TO HUMANS
QUARTZ (SiO2) 14808-60-7
(SILICA DUST, CRYSTALLINE)
GROUP 2B: POSSIBLY CARCINOGENIC TO HUMANS
TITANIUM DIOXIDE; [IN POWDER FORM CONTAINING 1 % OR MORE OF PARTICLES WITH
AERODYNAMIC DIAMETER </= 10 (MICRO)M] 13463-67-7
GROUP 2B: POSSIBLY CARCINOGENIC TO HUMANS
CARBON BLACK 1333-86-4
GROUP 2B: POSSIBLY CARCINOGENIC TO HUMANS
ETHYLBENZENE 100-41-4
OSHA: OSHA SPECIFICALLY REGULATED CARCINOGEN
QUARTZ (SiO2) 14808-60-7
(CRYSTALLINE SILICA)
NTP: KNOWN TO BE HUMAN CARCINOGEN
QUARTZ (SiO2) 14808-60-7
(SILICA, CRYSTALLINE (RESPIRABLE SIZE))
REPRODUCTIVE TOXICITY: NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
STOT-SINGLE EXPOSURE: NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
STOT-REPEATED EXPOSURE:
MAY CAUSE DAMAGE TO ORGANS THROUGH PROLONGED OR REPEATED EXPOSURE IF
INHALED. ONCE SENSITIZED, A SEVERE ALLERGIC REACTION MAY OCCUR WHEN
SUBSEQUENTLY EXPOSED TO VERY LOW LEVELS.
ASPIRATION TOXICITY: NOT CLASSIFIED BASED ON AVAILABLE INFORMATION.
FURTHER INFORMATION:
PRODUCT:
REMARKS:
CARBON BLACK (1333-86-4)
ANIMAL TOXICITY: RAT, ORAL, DURATION 2 YEAR
EFFECT: NO TUMORS
MOUSE, ORAL, DURATION 2 YEARS
EFFECT: NO TUMORS
MOUSE, DERMAL, DURATION 18 MONTHS
EFFECT: NO SKIN TUMORS
RAT, INHALATION, DURATION 2 YEARS
TARGET ORGAN: LUNGS
EFFECT: INFLAMMATION, FIBROSIS, TUMORS
NOTE:
TUMORS IN THE RAT LUNG ARE CONSIDERED TO BE RELATED TO THE "PARTICLE
OVERLOAD PHENOMENON" RATHER THAN TO A SPECIFIC CHEMICAL EFFECT OF CARBON
BLACK ITSELF IN THE LUNG. THESE EFFECTS IN RATS HAVE BEEN REPORTED IN MANY
STUDIES ON OTHER POORLY SOLUBLE INORGANIC PARTICLES AND APPEAR TO BE RAT
SPECIFIC. TUMORS HAVE NOT BEEN OBSERVED IN OTHER SPECIES (I.E., MOUSE AND
HAMSTER) FOR CARBON BLACK OR OTHER POORLY SOLUBLE PARTICLES UNDER SIMILAR
CIRCUMSTANCES AND STUDY CONDITIONS.
MORTALITY STUDIES (HUMAN DATA):
A STUDY ON CARBON BLACK PRODUCTION WORKERS IN THE UK (SORAHAN, 2001) FOUND
AN INCREASED RISK OF LUNG CANCER IN TWO OF THE FIVE PLANT STUDIED; HOWEVER,
THE INCREASE WAS NOT RELATED TO THE DOSE OF CARBON BLACK. THUS, THE AUTHORS
DID NOT CONSIDER THE INCREASED RISK IN LUNG CANCER TO BE DUE TO CARBON
BLACK EXPOSURE. A GERMAN STUDY OF CARBON BLACK WORKERS AT ONE PLANT
(MORFELD, 2006; BUECHTE, 2006) FOUND A SIMILAR INCREASE IN LUNG CANCER RISK
BUT, LIKE THE SOROHAN, 2001 (UK STUDY) FOUND NO ASSOCIATION WITH CARBON
BLACK EXPOSURE. A LARGE US STUDY OF 18 PLANTS SHOWED A REDUCTION IN LUNG
CANCER RISK IN CARBON BLACK PRODUCTION WORKERS (DELL, 2006). BASED UPON
THESE STUDIES, THE FEBRUARY 2006 WORKING GROUP AT THE INTERNATIONAL AGENCY
FOR RESEARCH ON CANCER (IARC) CONCLUDED THAT THE HUMAN EVIDENCE FOR
CARCINOGENICITY WAS INADEQUATE (IARC, 2010). SINCE THE IARC EVALUATION OF
CARBON BLACK, SORAHAN AND HAR-RINGTON (2007) HAVE REANALYZED THE UK STUDY
DATA USING AN ALTERNATIVE EXPOSURE HYPOTHESIS AND FOUND A POSITIVE
ASSOCIATION WITH CARBON BLACK EXPOSURE IN TWO OF THE FIVE PLANTS. THE SAME
EXPOSURE HYPOTHESIS WAS APPLIED BY MORFELD AND MCCUNNEY (2009) TO THE
GERMAN COHORT; IN CONTRAST, THEY FOUND NO ASSOCIATION BETWEEN CARBON BLACK
EXPOSURE AND LUNG CANCER RISK AND, THUS, NO SUPPORT FOR THE ALTERNATIVE
EXPOSURE HYPOTHESIS USED BY SORAHAN AND HARRINGTON. OVERALL, AS A RESULT
OF THESE DETAILED INVESTIGATIONS, NO CAUSA-TIVE LINK BETWEEN CARBON BLACK
EXPOSURE AND CANCER RISK IN HUMANS HAS BEEN DEMONSTRATED.
IARC CANCER CLASSIFICATION:
IN 2006 IARC RE-AFFIRMED ITS 1995 FINDING THAT THERE IS "INADEQUATE
EVIDENCE" FROM HUMAN HEALTH STUDIES TO ASSESS WHETHER CARBON BLACK CAUSES
CANCER IN HUMANS. IARC CONCLUDED THAT THERE IS "SUFFICIENT EVIDENCE" IN
EXPERIMENTAL ANIMAL STUDIES FOR THE CARCINOGEN-ICITY OF CARBON BLACK.
IARC'S OVERALL EVALUATION IS THAT CARBON BLACK IS "POSSIBLY CARCINOGENIC TO
HUMANS" (GROUP 2B)". THIS CONCLUSION WAS BASED ON IARC'S GUIDELINES, WHICH
GENERALLY REQUIRE SUCH A CLASSIFICATION IF ONE SPECIES EXHIBITS
CARCINOGENICITY IN TWO OR MORE ANIMAL STUDIES (IARC, 2010).
SOLVENT EXTRACTS OF CARBON BLACK WERE USED IN ONE STUDY OF RATS IN WHICH
SKIN TUMORS WERE FOUND AFTER DERMAL APPLICATION AND SEVERAL STUDIES OF
MICE IN WHICH SARCOMAS WERE FOUND FOLLOWING SUBCUTANEOUS INJECTION. IARC
CONCLUDED THAT THERE WAS "SUFFICIENT EVIDENCE" THAT CARBON BLACK EXTRACTS
CAN CAUSE CANCER IN ANIMALS (GROUP 2B).
ICGIH CANCER CLASSIFICATION:
CONFIRMED ANIMAL CARCINOGEN WITH UNKNOWN RELEVANCE TO HUMANS (CATEGORY A3
CARCINOGEN).
ASSESSMENT:
APPLYING THE GUIDELINES OF SELF-CLASSIFICATION UNDER THE GLOBALLY
HARMONIZED SYSTEM OF CLASSIFICATION AND LABELING OF CHEMICALS, CARBON BLACK
IS NOT CLASSIFIED AS A CARCINOGEN. LUNG TUMORS ARE INDUCED IN RATS AS A
RESULT OF REPEATED EXPOSURE TO INERT, POORLY SOLUBLE PARTICLES LIKE CARBON
BLACK AND OTHER POORLY SOLUBLE PARTICLES. RATS TUMORS ARE A RESULT OF A
SECONDARY NON-GENOTOXIC MECHANISM THAT HAS QUESTIONABLE RELEVANCE FOR
CLASSIFICATION IN HUMANS. IN SUPPORT OF THIS OPINION, THE CLP GUIDANCE FOR
SPECIFIC TARGET ORGAN TOXICITY - REPEATED EXPOSURE (STOT-RE), CITES LUNG
OVERLOAD UNDER MECHANISMS NOT RELEVANT TO HUMANS. HUMAN HEALTH STUDIES SHOW
THAT EXPOSURE TO CARBON BLACK DOES NOT INCREASE THE RISK TO
CARCINOGENICITY.
TITANIUM DIOXIDE (13463-67-7):
IN LIFETIME INHALATION STUDIES OF RATS, AIRBORNE RESPIRABLE-SIZE TITANIUM
DIOXIDE PARTICLES HAVE SHOWN TO CAUSE AN INCREASE IN LUNG TUMORS AT
CONCENTRATIONS ASSOCIATED WITH SUBSTANTIAL PARTICLE LUNG BURDENS AND
CONSEQUENTIAL PULMONARY OVERLOAD AND INFLAMMATION. THE POTENTIAL FOR THESE
ADVERSE HEALTH EFFECTS APPEARS TO BE CLOSELY RELATED TO THE PARTICLE SIZE
AND THE AMOUNT OF THE EXPOSED SURFACE AREA THAT COMES INTO CONTACT WITH THE
LUNG. HOWEVER, TESTS WITH OTHER LABORATORY ANIMALS SUCH AS MICE AND
HAMSTERS, INDICATE THAT RATS ARE SIGNIFICANTLY MORE SUSCEPTIBLE TO THE
PULMONARY OVERLOAD AND INFLAMMATION THAT CAUSES LUNG CANCER.
EPIDEMIOLOGICAL STUDIES DO NOT SUGGEST AN INCREASED RISK OF CANCER IN
HUMANS FROM OCCUPATIONAL EXPOSURE TO TITANIUM DIOXIDE. TITANIUM DIOXIDE
HAS BEEN CHAR-ACTERIZED BY IARC AS POSSIBLY CARCINOGENIC TO HUMANS
(GROUP 2B) THROUGH INHALATION (NOT INGESTION). IT HAS NOT BEEN
CHARACTERIZED AS A POTENTIAL CARCINOGEN BY EITHER NTP OR OSHA.
QUARTZ (14808-60-7):
THIS CLASSIFICATION IS RELEVANT WHEN EXPOSED TO QUARTZ (SILICON DIOXIDE)
IN DUST OR POWDER FORM ONLY, INCLUDING CURED PRODUCT THAT IS SUBJECT TO
SANDING, GRINDING, CUTTING, OR OTHER SURFACE PREPARATION ACTIVITIES.
| SECTION 12. ECOLOGICAL INFORMATION | |
ECOTOXICITY:
COMPONENTS:
XYLENE:
TOXICITY TO ALGAE/AQUATIC PLANTS:
EC50 (PSEUDOKIRCHNERIELLA SUBCAPITATA (GREEN ALGAE)): 2.2 MG/L
METHOD: OECD TEST GUIDELINE 201
TOXICITY TO FISH (CHRONIC TOXICITY):
NOEC (ONCORHYNCHUS MYKISS (RAINBOW TROUT)): >1.3 MG/L
EXPOSURE TIME: 56 D
TOXICITY TO DAPHNIA AND OTHER AQUATIC INVERTEBRATES (CHRONIC TOXICITY):
NOEC (DAPHNIA): 1.17 MG/L
EXPOSURE TIME: 7 D
ETHYLBENZENE:
PERSISTENCE AND DEGRADABILITY: NO DATA AVAILABLE
BIOACCUMULATIVE POTENTIAL: NO DATA AVAILABLE
MOBILITY IN SOIL: NO DATA AVAILABLE
OTHER ADVERSE EFFECTS:
PRODUCT:
ADDITIONAL ECOLOGICAL INFORMATION:
DO NOT EMPTY INTO DRAINS; DISPOSE OF THIS MATERIAL AND ITS CONTAINER IN A
SAFE WAY. AVOID DISPERSAL OF SPILLED MATERIAL AND RUNOFF AND CONTACT WITH
SOIL, WATERWAYS, DRAINS AND SEWERS.
| SECTION 13. DISPOSAL CONSIDERATIONS | |
DISPOSAL METHODS:
WASTE FROM RESIDUES:
DISPOSAL OF THIS PRODUCT, SOLUTIONS AND ANY BY-PRODUCTS SHOULD AT ALL TIMES
COMPLY WITH THE REQUIREMENTS OF ENVIRONMENTAL PROTECTION AND WASTE DISPOSAL
LEGISLATION AND ANY REGIONAL LOCAL AUTHORITY REQUIREMENTS.
CONTAMINATED PACKAGING:
EMPTY CONTAINERS SHOULD BE TAKEN TO AN APPROVED WASTE HANDLING SITE FOR
RECYCLING OR DISPOSAL.
| SECTION 14. TRANSPORT INFORMATION | |
INTERNATIONAL REGULATIONS:
IATA-DGR: NOT REGULATED AS A DANGEROUS GOOD
IMDG-CODE: NOT REGULATED AS A DANGEROUS GOOD
DOMESTIC REGULATION:
49 CFR: NOT REGULATED AS A DANGEROUS GOOD
| SECTION 15. REGULATORY INFORMATION | |
TSCA LIST:
ALL CHEMICAL SUBSTANCES IN THIS PRODUCT ARE EITHER LISTED ON THE TSCA
INVENTORY OR ARE IN COMPLIANCE WITH A TSCA INVENTORY EXEMPTION.
EPCRA - EMERGENCY PLANNING AND COMMUNITY RIGHT-TO-KNOW:
CERCLA REPORTABLE QUANTITY:
THIS MATERIAL DOES NOT CONTAIN ANY COMPONENTS WITH A CERCLA RQ.
SARA 304 EXTREMELY HAZARDOUS SUBSTANCES REPORTABLE QUANTITY:
THIS MATERIAL DOES NOT CONTAIN ANY COMPONENTS WITH A SECTION 304 EHS RQ.
SARA 302 EXTREMELY HAZARDOUS SUBSTANCES THRESHOLD PLANNING QUANTITY:
THIS MATERIAL DOES NOT CONTAIN ANY COMPONENTS WITH A SECTION 302 EHS TPQ.
SARA 311/312 HAZARDS:
RESPIRATORY OR SKIN SENSITIZATION
CARCINOGENICITY
SPECIFIC TARGET ORGAN TOXICITY (SINGLE OR REPEATED EXPOSURE)
SARA 313:
THE FOLLOWING COMPONENTS ARE SUBJECT TO REPORTING LEVELS ES-TABLISHED BY
SARA TITLE III, SECTION 313:
XYLENE 1330-20-7 >= 1 - <5 %
ETHYLBENZENE 100-41-4 >= 0.1 - <1 %
CLEAN AIR ACT:
THE FOLLOWING CHEMICAL(S) ARE LISTED AS HAP UNDER THE U.S. CLEAN AIR ACT,
SECTION 112 (40 CFR 61):
XYLENE 1330-20-7 >= 1 - <5 %
CALIFORNIA PROP 65:
WARNING: CANCER AND REPRODUCTIVE HARM - WWW.P65WARNINGS.CA.GOV
| SECTION 16. OTHER INFORMATION | |
FULL TEXT OF OTHER ABBREVIATIONS:
ACGIH: USA. ACGIH THRESHOLD LIMIT VALUES (TLV)
OSHA P0:
USA. OSHA - TABLE Z-1 LIMITS FOR AIR CONTAMINANTS - 1910.1000
OSHA Z-1:
USA. OCCUPATIONAL EXPOSURE LIMITS (OSHA) - TABLE Z-1 LIM-ITS FOR AIR
CONTAMINANTS
OSHA Z-3:
USA. OCCUPATIONAL EXPOSURE LIMITS (OSHA) - TABLE Z-3 MIN-ERAL DUSTS
ACGIH / TWA: 8-HOUR, TIME-WEIGHTED AVERAGE
ACGIH / STEL: SHORT-TERM EXPOSURE LIMIT
OSHA P0 / TWA: 8-HOUR TIME WEIGHTED AVERAGE
OSHA P0 / STEL: SHORT-TERM EXPOSURE LIMIT
OSHA P0 / C: CEILING LIMIT
OSHA Z-1 / TWA: 8-HOUR TIME WEIGHTED AVERAGE
OSHA Z-1 / C: CEILING
OSHA Z-3 / TWA: 8-HOUR TIME WEIGHTED AVERAGE
NOTES TO READER:
THE INFORMATION CONTAINED IN THIS SAFETY DATA SHEET APPLIES ONLY TO THE
ACTUAL SIKA CORPORATION ("SIKA") PRODUCT IDENTIFIED AND DESCRIBED HEREIN.
THIS INFORMATION IS NOT INTENDED TO ADDRESS, NOR DOES IT ADDRESS THE USE
OR APPLICATION OF THE IDENTIFIED SIKA PRODUCT IN COMBINATION WITH ANY OTHER
MATERIAL, PRODUCT OR PROCESS. ALL OF THE INFORMATION SET FORTH HEREIN IS
BASED ON TECHNICAL DATA RE-GARDING THE IDENTIFIED PRODUCT THAT SIKA
BELIEVES TO BE RELIABLE AS OF THE DATE HEREOF. PRIOR TO EACH USE OF ANY
SIKA PRODUCT, THE USER MUST ALWAYS READ AND FOLLOW THE WARNINGS AND
INSTRUCTIONS ON THE PRODUCT'S CURRENT PRODUCT DATA SHEET, PRODUCT LABEL
AND SAFETY DATA SHEET FOR EACH SIKA PRODUCT, WHICH ARE AVAILABLE AT WEB
SITE AND/OR TELEPHONE NUMBER LISTED IN SECTION 1 OF THIS SDS.
SIKA MAKES NO WARRANTIES EXPRESS OR IMPLIED AND ASSUMES NO LIABILITY
ARISING FROM THIS INFORMATION OR ITS USE. SIKA SHALL NOT BE LIABLE UNDER
ANY LEGAL THEORY FOR SPECIAL OR CONSEQUENTIAL DAMAGES AND SHALL NOT BE
RESPONSIBLE FOR THE USE OF THIS PRODUCT IN A MANNER TO INFRINGE ON ANY
PATENT OR ANY OTHER INTELLECTUAL PROPERTY RIGHTS HELD BY OTHERS.
ALL SALES OF SIKA PRODUCTS ARE SUBJECT TO ITS CURRENT TERMS AND CONDITIONS
OF SALE AVAILABLE AT WWW.SIKAUSA.COM OR 201-933-8800.
REVISION DATE: 03/30/2021
000000604251
US / Z8